412 related articles for article (PubMed ID: 25526712)
1. Bone health management in men undergoing ADT: examining enablers and barriers to care.
Damji AN; Bies K; Alibhai SM; Jones JM
Osteoporos Int; 2015 Mar; 26(3):951-9. PubMed ID: 25526712
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer.
Nadler M; Alibhai S; Catton P; Catton C; To MJ; Jones JM
BJU Int; 2013 Jun; 111(8):1301-9. PubMed ID: 23351062
[TBL] [Abstract][Full Text] [Related]
3. Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
Alibhai SM; Rahman S; Warde PR; Jewett MA; Jaffer T; Cheung AM
Urology; 2006 Jul; 68(1):126-31. PubMed ID: 16844454
[TBL] [Abstract][Full Text] [Related]
4. Management of osteoporosis in men on androgen deprivation therapy.
Adler RA
Maturitas; 2011 Feb; 68(2):143-7. PubMed ID: 21129866
[TBL] [Abstract][Full Text] [Related]
5. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
Dhanapal V; Reeves DJ
J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.
Diamond TH; Higano CS; Smith MR; Guise TA; Singer FR
Cancer; 2004 Mar; 100(5):892-9. PubMed ID: 14983482
[TBL] [Abstract][Full Text] [Related]
7. Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.
Grossmann M; Hamilton EJ; Gilfillan C; Bolton D; Joon DL; Zajac JD
Med J Aust; 2011 Mar; 194(6):301-6. PubMed ID: 21426285
[TBL] [Abstract][Full Text] [Related]
8. The impact of bone mineral density testing, fracture assessment, and osteoporosis education in men treated by androgen deprivation for prostate cancer: a pilot study.
Nadler M; Alibhai S; Catton P; Catton C; Jones J
Support Care Cancer; 2014 Sep; 22(9):2409-15. PubMed ID: 24696083
[TBL] [Abstract][Full Text] [Related]
9. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
Tanvetyanon T
Cancer; 2005 Jan; 103(2):237-41. PubMed ID: 15597384
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.
Poulsen MH; Frost M; Abrahamsen B; Brixen K; Walter S
Scand J Urol; 2014 Aug; 48(4):350-5. PubMed ID: 24548220
[TBL] [Abstract][Full Text] [Related]
11. Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management?
Sharqawi A; Hewitt K; Alexander C; El-Sakka AI; Lee L
Arch Osteoporos; 2022 Nov; 17(1):143. PubMed ID: 36376762
[TBL] [Abstract][Full Text] [Related]
12. Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.
Panju AH; Breunis H; Cheung AM; Leach M; Fleshner N; Warde P; Duff-Canning S; Krahn M; Naglie G; Tannock I; Tomlinson G; Alibhai SM
BJU Int; 2009 Mar; 103(6):753-7. PubMed ID: 19007370
[TBL] [Abstract][Full Text] [Related]
13. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.
Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH
JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269
[TBL] [Abstract][Full Text] [Related]
14. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.
Adler RA; Hastings FW; Petkov VI
Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207
[TBL] [Abstract][Full Text] [Related]
15. Bone health care for patients with prostate cancer receiving androgen deprivation therapy.
Tsang DS; Alibhai SM
Hosp Pract (1995); 2014 Apr; 42(2):89-102. PubMed ID: 24769788
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis due to androgen deprivation therapy in men with prostate cancer.
Daniell HW
Urology; 2001 Aug; 58(2 Suppl 1):101-7. PubMed ID: 11502461
[TBL] [Abstract][Full Text] [Related]
17. Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT).
Chahin R; Gulamhusein H; Breunis H; Alibhai SM
Support Care Cancer; 2016 Nov; 24(11):4713-20. PubMed ID: 27370648
[TBL] [Abstract][Full Text] [Related]
18. Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D.
Alibhai SM; Mohamedali HZ; Gulamhusein H; Panju AH; Breunis H; Timilshina N; Fleshner N; Krahn MD; Naglie G; Tannock IF; Tomlinson G; Warde P; Duff Canning S; Cheung AM
Osteoporos Int; 2013 Oct; 24(10):2571-9. PubMed ID: 23563932
[TBL] [Abstract][Full Text] [Related]
19. Quantitative ultrasound of the heel as triage test to measure bone mineral density compared with dual energy X-ray absorptiometry in men with prostate cancer commencing with androgen deprivation therapy.
van Casteren-Messidoro C; Huisman AM; Birnie E; van Gelder M; van de Geijn FE; Hamberg P
Neth J Med; 2014 Dec; 72(10):528-32. PubMed ID: 26219758
[TBL] [Abstract][Full Text] [Related]
20. Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial.
Alibhai SMH; Breunis H; Timilshina N; Hamidi MS; Cheung AM; Tomlinson GA; Manokumar T; Samadi O; Sandoval J; Durbano S; Warde P; Jones JM
Cancer; 2018 Mar; 124(6):1132-1140. PubMed ID: 29211305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
